GW Pharmaceuticals Plc ADR (GWPH)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

SOVEREIGN HOUSE HISTON, CAMBRIDGE CB24 9BZ, UNITED KINGDOM

GW Pharmaceuticals plc, together with its subsidiaries, engages in the research, development, and commercialization of a range of cannabinoid prescription medicines. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in treatment of cancer pain.

Data based on most recent fiscal year report
Market Cap3.739 Billion Shares Outstanding30.89 Million Avg Volume719.612 Thousand
1-Yr BETA vs S&P TR1.101 Current Ratio6.66 Quick Ratio6.34
View SEC Filings from GWPH instead.

View recent insider trading info

Funds Holding GWPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GWPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1.1 Million total shares from 8 transactions

Exercise Derivative Conversion (M)

202.2 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOVER JUSTIN D. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
563,525 2020-02-03 7

GUY GEOFFREY W DR EXECUTIVE CHAIRMAN

  • Officer
  • Director
6,821,521 2020-01-15 4

NOBLE JAMES

  • Director
0 2020-01-13 2

MACKEY CATHERINE J

  • Director
0 2020-01-09 2

BROWN CABOT

  • Director
20,232 2020-01-03 2

SECOR ALICIA

  • Director
17,736 2020-01-03 3

LYNCH THOMAS G

  • Director
287,500 2019-12-31 1

SNYDER DOUGLAS B. CHIEF LEGAL OFFICER

  • Officer
73,740 2019-08-19 5

WALDEGRAVE WILLIAM A.

  • Director
0 2019-07-10 2

CLINE DARREN S

  • Director
35,468 2019-06-25 2

TOVEY CHRISTOPHER J. CHIEF OPERATING OFFICER

  • Officer
2,503 2019-06-03 4

GIACOBELLO SCOTT M. CHIEF FINANCIAL OFFICER

  • Officer
87,096 2019-05-18 3

KNAPPERTZ VOLKER CHIEF MEDICAL OFFICER

  • Officer
85,824 2019-05-18 3

GANGOLLI JULIAN S PRESIDENT, NORTH AMERICA

  • Officer
106,548 2019-05-10 2

GEORGE ADAM D. SECRETARY

  • Officer
10,000 2019-05-07 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GOVER JUSTIN D. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-03 S 19,548 $9.71 d 563,525 563,525.00 direct yes

GOVER JUSTIN D. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-03 M 202,224 $0.00 a 765,749 563,525.00 direct

GOVER JUSTIN D. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-03 S 110,964 $9.63 d 583,073 563,525.00 direct yes

GOVER JUSTIN D. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-03 M 202,224 d 7 563,525.00 direct

GOVER JUSTIN D. - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-03 S 71,712 $9.57 d 694,037 563,525.00 direct yes

GUY GEOFFREY W DR - Director - Officer EXECUTIVE CHAIRMAN

2020-01-15 S 600,000 $9.42 d 6,821,521 6,821,521.00 direct yes

GUY GEOFFREY W DR - Director - Officer EXECUTIVE CHAIRMAN

2020-01-15 S 300,000 $9.47 d 7,421,521 6,821,521.00 direct yes

MACKEY CATHERINE J - Director

2020-01-03 S 1,536 $8.54 d 17,748 17,748.00 direct

BROWN CABOT - Director

2020-01-03 S 3,576 $8.58 d 20,232 20,232.00 direct yes

SECOR ALICIA - Director

2020-01-03 S 1,536 $8.53 d 17,736 17,736.00 direct

Elevate your investments